Basal cell carcinomas (BCCs) are the most common cancer in the US with an annual incidence of 750,000. The highly stromal-dependent growth of BCCs makes them ideal models for the analysis of tumor-stromal interactions. Recently the central role of the Sonic hedgehog (Shh) signaling pathway in the epithelium of these tumors has been elucidated. Their preliminary evidence supports the hypothesis that the surrounding tumor stroma regulates BCC growth by controlling the transcriptional induction of Shh target genes in the epithelium. Greater knowledge is needed to understand mechanistically how stromal cells accomplish this crucial function.
The aim of this grant is identify the stromal cells and genes that regulate epithelial Shh target gene induction to maintain BCC growth and malignant potential. They proposes to: 1) Determine why keratinocytes fail to induce the Gli genes in the absence of a stromal environment; 2) Identify the stromal cells which allow epithelial Shh target gene expression in organotypic skin cultures; and 3) Identify candidate stromal signaling genes using high density cDNA arrays. At the end of the proposed funding period they will have a greater mechanistic understanding how epithelial Shh target genes are regulated by signals from the surrounding stroma. Their studies should give insight into how the growth of other epithelial tumors are regulated by their stroma and may lead to the development of new anti-tumor agents.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR046786-04
Application #
6764250
Study Section
Pathology B Study Section (PTHB)
Program Officer
Moshell, Alan N
Project Start
2001-07-01
Project End
2006-05-31
Budget Start
2004-06-01
Budget End
2005-05-31
Support Year
4
Fiscal Year
2004
Total Cost
$335,940
Indirect Cost
Name
Stanford University
Department
Dermatology
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Kuonen, François; Surbeck, Isabelle; Sarin, Kavita Y et al. (2018) TGF?, Fibronectin and Integrin ?5?1 Promote Invasion in Basal Cell Carcinoma. J Invest Dermatol 138:2432-2442
Whitson, Ramon J; Lee, Alex; Urman, Nicole M et al. (2018) Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas. Nat Med 24:271-281
Whitson, Ramon J; Oro, Anthony E (2017) Soil Primes the Seed: Epigenetic Landscape Drives Tumor Behavior. Cell Stem Cell 20:149-150
Mirza, Amar N; Fry, Micah A; Urman, Nicole M et al. (2017) Combined inhibition of atypical PKC and histone deacetylase 1 is cooperative in basal cell carcinoma treatment. JCI Insight 2:
Urman, Nicole M; Mirza, Amar; Atwood, Scott X et al. (2016) Tumor-Derived Suppressor of Fused Mutations Reveal Hedgehog Pathway Interactions. PLoS One 11:e0168031
Ally, Mina S; Ransohoff, Katherine; Sarin, Kavita et al. (2016) Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma. JAMA Dermatol 152:452-6
Wang, Kevin; Lee, Carolyn S; Marinkovich, M Peter et al. (2016) Factors That May Promote an Effective Local Research Environment. J Invest Dermatol 136:1529-1531
Kwon, Gina P; Ally, Mina Sarah; Bailey-Healy, Irene et al. (2016) Update to an open-label clinical trial of vismodegib as neoadjuvant before surgery for high-risk basal cell carcinoma (BCC). J Am Acad Dermatol 75:213-5
Danial, Christina; Sarin, Kavita Y; Oro, Anthony E et al. (2016) An Investigator-Initiated Open-Label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib. Clin Cancer Res 22:1325-9
Atwood, Scott X; Sarin, Kavita Y; Li, Jiang R et al. (2015) Rolling the Genetic Dice: Neutral and Deleterious Smoothened Mutations in Drug-Resistant Basal Cell Carcinoma. J Invest Dermatol 135:2138-2141

Showing the most recent 10 out of 39 publications